Mary Washington Hospital is a 451-bed, full-service hospital in Fredericksburg, Virginia. It is one of seven level II trauma centers in Virginia and was ranked 6th best in the state by U.S. News & World Report.

There are 471 beds in Mary Washington Hospital.

During the past decade, Mary Washington Hospital conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mary Washington Hospital" #1 sponsor was "Abbott Medical Devices" with 3 trials, followed by "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "National Cancer Institute (NCI)" with 3 trials sponsored, "Alexion" with 1 trials sponsored and "Concure Oncology-Breast Microseed Inc." with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mary Washington Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 5 trials as a collaborator, "Acelis Connected Health" with 1 trials as a collaborator, "American Academy of Pediatrics" with 1 trials as a collaborator, "Avania" with 1 trials as a collaborator and "Canadian Cancer Trials Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Mary Washington Hospital" are "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (3 trials), "Stage II Lung Non-Small Cell Cancer AJCC v7" (3 trials), "Stage IIIA Lung Non-Small Cell Cancer AJCC v7" (3 trials), "Breast Cancer" (2 trials) and "Coronary Artery Disease" (2 trials). Many other conditions were trialed in "Mary Washington Hospital" in a lesser frequency.

Most popular intervention types in "Mary Washington Hospital" are "Drug" (6 trials), "Other" (6 trials), "Device" (5 trials), "Procedure" (5 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Clinical Observation" (3 trials), "Biospecimen Collection" (2 trials), "Computed Tomography" (2 trials), "Crizotinib" (2 trials) and "Laboratory Biomarker Analysis" (2 trials). Other intervention names were less common.

The vast majority of trials in "Mary Washington Hospital" are 15 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Mary Washington Hospital". undefined are not yet recruiting, 4 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Mary Washington Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Mary Washington Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".

Mary Washington Hospital has several departments that took part in Clinical trials: "Mary Washington Hospital Research Department" - 3 trials